Astrana Health, Inc.

ASTH Healthcare Medical Care Facilities

Astrana Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 56.4% from fiscal 2024. In the quarter to June 2026, revenue grew 48.5%, EPS grew 110.5%, free cash flow fell 67.7% and total debt rose 126.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

36.81 1.22 −3.21%
Market cap
$1.9B
P/E
44.3×
Fwd P/E
29.7×
Dividend yield
—
F-score
4/9
Altman Z
2.39
Beneish M
−2.19
Dividend safety
50/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 4 4 5
ROE
1.27% 2.98% 3.86% 5.03%
ROA
0.54% 1.26% 1.64% 2.18%
ROIC
2.77% 3.50% 3.96% 4.56%
Return on Tangible Assets
3.08% 7.36% 9.50% 17.32%
Average Days of Receivables
49.29 46.19 51.28 46.45
Free Cash Flow per Share
1.97 2.13 3.17 1.92
Free Cash Flow
96.96 104.49 154.99 94.38
Other line items

Show all line items

Columns are period end dates